CPHI vs TROW · rev $4.1M vs P/E 12, rev $7.09B
China Pharma Holdings Inc (CPHI) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported TROW revenue for 2024-12-31 was $7.09B. Net income was $2.14B. Revenue was up 9.8% from 2023-12-31 to 2024-12-31. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
CPHI currently screens at market cap $29.0M. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the CPHI and TROW stock pages for the full models.
Not investment advice.